Reports from Merck Research Labs Provide New Insights into DNA Gyrase (In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase)

MLA

“Reports from Merck Research Labs Provide New Insights into DNA Gyrase (In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase).” Obesity, Fitness & Wellness Week, Sept. 2016, p. 1955. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.463887309&authtype=sso&custid=ns315887.

APA

Reports from Merck Research Labs Provide New Insights into DNA Gyrase (In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase). (2016, September 24). Obesity, Fitness & Wellness Week, 1955.

Chicago

Obesity, Fitness & Wellness Week. 2016. “Reports from Merck Research Labs Provide New Insights into DNA Gyrase (In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase),” September 24. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.463887309&authtype=sso&custid=ns315887.